Login to Your Account



Immunicum Shares Rise on Cancer Vaccine Progress

By Cormac Sheridan
Staff Writer

Wednesday, August 21, 2013
Shares in Immunicum AB surged more than 40 percent Monday on promising signals from a Phase I/II trial of its kidney cancer vaccine, Intuvax.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription